Gene switches enable 3D-printed bone tissue to autonomously grow new blood vessels, offering hope for treating bone defects caused by trauma or infection
An interdisciplinary team at Pennsylvania State University in the United States has achieved a break...
FDA Approves Mounjaro to Reduce Cardiovascular Risk in Type 2 Diabetes
The U.S. Food and Drug Administration (FDA) has approved Mounjaro (tirzepatide) to reduce cardiovasc...
Germany's IGEL Partners with Teguar to Expand Medical and Industrial Endpoint Options
IGEL has announced that Teguar has joined the IGEL-Ready ecosystem, with select hardware validated f...
FDA Authorizes Robot That Can Independently Draw Blood
According to Phys.org, the U.S. Food and Drug Administration (FDA) has approved Aletta, the first ro...
Johnson & Johnson's IMAAVY Receives FDA Approval as the World's First Dedicated Therapy for wAIHA
On August 24, Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has appro...
China's innovative drugs accelerate global expansion
Since the start of this year, innovative drugs have emerged as a dark horse on China's export "best-...
Genentech, a Roche Group Company, Invests $750 Million to Expand Oregon Fill-Finish Facility
On August 20, Genentech, a member of the Roche Group, announced plans to invest approximately $750 m...
DAMO Academy and Shengjing Hospital Launch Liver Cancer AI Diagnostic Model DAMO LiON, Published in Nature Medicine
On August 24, Alibaba DAMO Academy, together with Shengjing Hospital of China Medical University and...
Stäubli Robotics Showcases Medical Automation Solutions at September Exhibition in Ireland
Stäubli Robotics will showcase its portfolio of automation solutions for the medical technology indu...
FDA Approves Regeneron's Rare Bone Disease Drug Pasatru, Priced Up to $2.1 Million Annually
On August 19, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals' Pasatr...
Trump Nominates Overton to Lead U.S. FDA
On August 19, U.S. President Trump nominated Heidi Overton, Deputy Director of the White House Domes...
WuXi XDC Singapore Site BCM3 Achieves First Overseas GMP Release
WuXi XDC (WuXi XDC Cayman Inc., stock code: 2268.HK) recently announced that the BCM3 dual-function ...
Chugai Grants GSK Exclusive Global License for AID351
On August 17, Chugai Pharmaceutical and GSK signed an exclusive license agreement for the anti-dengu...
Sinovac Biotech's Infliximab Biosimilar Approved in Thailand
On August 18, Reminton®, an infliximab biosimilar introduced by Sinovac Biotech and developed by Mab...
Kunming University of Science and Technology in China Discovers New Antidepressant Target of Qingyangshen Saponins
The team of Professors Xu Tianrui and Xiang Cheng from the Faculty of Life Science and Technology at...
AstraZeneca's Tezspire Officially Launched in China
On August 17, AstraZeneca announced the official launch of Tezspire in China. The product's generic ...
Google to Launch Insulin Resistance Trends Feature for Pixel Watch in 2026
At the Made by Google 2026 event, Google unveiled the Insulin Resistance Trends feature, adding bloo...
China's Aurisco Pharmaceutical Becomes World's First Generic Oligonucleotide Manufacturer to Pass FDA Inspection
Aurisco Pharmaceutical announced on August 14, 2026, that its facility in Yangzhou, China, has passe...
Quantinuum, NVIDIA, and Pfizer Validate Quantum AI for Drug Discovery, Reducing Generation Time by 3-4 Orders of Magnitude
A research team from Quantinuum, NVIDIA, and Pfizer Inc. has proposed a generative quantum AI framew...
Teledyne to Acquire Varex for $1.1 Billion, Expected to Close in Early 2027
Teledyne Technologies Incorporated and Varex Imaging Corporation (hereinafter "Varex") jointly annou...
Portugal allocates €630 million to modernize the healthcare system
The Portuguese government has announced that, under the revised Recovery and Resilience Plan (PRR), ...
Bristol Myers Squibb Invests $2.3 Billion to Build Manufacturing Campus in Texas, U.S.
Bristol Myers Squibb (BMS) plans to invest $2.3 billion to build a manufacturing campus spanning app...
US FDA Rejects Novo Nordisk's $16.5B Plant, Korean CDMOs See Opportunity
The U.S. Food and Drug Administration (FDA) has refused to approve a key manufacturing facility owne...
South Korea's Biosolution Signs Cell Therapy Agreement with Hainan Boao International Hospital in China
South Korean biotech company Biosolution is introducing its flagship autologous chondrocyte therapy,...
Eupraxia Pharmaceuticals Reports Q2 2026 Net Loss of $14.5 Million
Eupraxia Pharmaceuticals Inc. reported financial results for the second quarter of 2026 on August 11...
Lupin's Sodium Zirconium Cyclosilicate Receives U.S. FDA Approval with Annual Sales of $568 Million
On August 10, Lupin Limited (Lupin) announced that its Abbreviated New Drug Application for Sodium Z...
U.S. AQUAPASS Completes Enrollment in Pivotal REFORM-HF Trial
AQUAPASS announced that it has completed patient enrollment in the pivotal clinical trial REFORM-HF ...
Stanford University Uses AI to Design Viral Genomes for the First Time, Synthesizing 16 Phages
Researchers at Stanford University, using generative artificial intelligence tools, have for the fir...
Novo Nordisk to Launch Oral Wegovy Tablets and 7.2 mg Injection Pen in Portugal
Novo Nordisk is set to introduce oral Wegovy tablets to the Portuguese market, available in four dos...
U.S. SCYNEXIS Reports Q2 Results and Initiates Phase 1 Clinical Trial of SCY-770
SCYNEXIS (NASDAQ: SCYX), a clinical-stage biotechnology company, reported its second-quarter financi...